Physical functioning and aging

In the table below, entries in the left column refer to the related documentation, while the values in the cells of columns LASA-B to LASA-J refer to the corresponding LASA-data files (e.g. ‘161‘ in column B refers to: ‘LASAB161‘). Table entries are hyperlinks. Hovering  over the waves in the header will show the years in which the corresponding measurements took place.

In case entries are preceeded by ‘o’, the corresponding files are related to the OSTEOPOR-dataset (e.g. o80 refers to ‘LASAo80′). Likewise, prefixes ‘g’, ‘z’, ‘zo(a)’, ‘zh’, ‘ch’, and ‘zd’ refer to other special datasets, more information will follow.

UC: Under Construction.

For more details about the LASA-waves, see Design LASA.

Note that some of the data are not yet available (in red).

LASA-wave BCDE2BFGH3BMBIJK
Cohort 1         
Cohort 2         
Cohort 3   
Migrant Cohort       
          
Blood pressureBCDE2BFGH3BMBIJ
Blood pressure/
pulse
– retests
151

151

151

151

151

151
151

151

151
151

151
151

151
151

151

151
151

151
Body compositionBCDE2BFGH3BMBIJ
Anthropometry

– Weight and height

– Calf measurement

– Ankle, Knee and
Pulse width

161

161

171

161

161



185
161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161




161

161

161


161

161

161


Weight and height
history and
weight change
IM

– tel. respondent*

160



160



160



160



160



160



160



160



160



160



160



714

160



714
Bio-electrical
impedance**
(subsample)

172 –
Birth weight
134134134 –
Perceived body
shape**
– scaled











145

345
145

345



145

345
145

345




DXA
(LASA ancillary study)
– Hip / lumbar spine scan
– Whole body scan





o41
o42


o41
o42



























Chronic diseasesBCDE2BFGH3BMBIJ
Self-report of
chronic diseasesIM

– nr. of diseases
reported

– tel. proxy*

– tel. respondent*

– longitudinally
cleaned

035


235







435
035


235



602

602


435
035


235



602

702


035


235



602

702


035


235







035


235



602

702


035


235



602

702


035


235



602

702


035


235







035


235







035


235



602

702


035


235



602

702


GP informationg01g01g01g01g01g01g01UCUC
Aortic calcification
(lateral radiographs)

zo22zo22
Diabetes mellitus
(algorithm)

zdc1zdc1zdc1zdc1zdc2zdc1
zdc2
zdc1
zdc2
zdc1
zdc2


zdc3
zdc1
zdc2
zdc3
UC
Rheumatoid
Arthritis
(algorithm)

UC
Osteoarthritis hip
and knee
(algorithm)

zoa1
zoa1zoa1 zoa1zoa2zoa1
zoa2
zoa1
zoa2
zoa1
zoa2


zoa3
zoa1
zoa2
zoa3
UC
Metabolic
syndrome

ch02
Allostatic Load
(algorithm)

X
Cardiovascular
diseases
(algorithm)

zh01zh01zh01
Parkinson: early P.
related signs**

096096
Decubitus
(bedsores)

116

159






















Hyperthyroidism**
182 182
Back pain182
182
182
Bedridden
182182
182
182
182
182
FertilityBCDE2BFGH3BMBIJ
Fertility (women)
119 1811 181 181
181
FallingBCDE2BFGH3BMBIJ
Falls

– tel. proxy*

– tel. respondent*

– Falls last year









605

605

187


605

705

187




































187






187












187
Falls: circumstances and
consequences

187
Falls: environmental
conditions (home)**

180
180
Falls: fear of falling
(FES: Falls Efficacy
Scale)

183
183
Falls: prevention of
fall accidents
(LASA ancillary study)

X
Falls: 3y prospective
fall calendar
(LASA ancillary study)

X
Falls: 1y prospective
fall calendar
(LASA ancillary study)

X
DizzinessIM
187
187
187
187
187
187
187
187
187
Adjustments and
walking aids**

187187187187187187187 –
Foot problems
185185185185– 
FracturesBCDE2BFGH3BMBIJ
Fractures

– total waves b-f

– per wave

– tel. proxy*

– tel. respondent*


zo13







zo13

186

605

605


zo13

186

605

705


zo13

186

605

705


zo13

186





zo13

186

605

705





186

605

705






186

605

705






186







186







186

605

705






186

605

705

Vertebral
deformities

zo22zo22
Quantitative
ultrasound of bone

o31o31
Frailty
BCDE2BFGH3BMBIJ
Various definitions
(e.g., frailty
phenotype,
frailty index)

XX  X  X  X  X   X  XXXXX
LifestyleBCDE2BFGH3BMBIJ
Alcohol useIM
– scaled
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
Diet and food
consumption


Lifestyle study
(LASA ancillary study)


Nutrition and
food-related
behaviour
(LASA ancillary study)


with subtopics:
– Eating patterns
– Weight(loss)
and appetite
– Mindful eating
– Meals and snack
– Interoceptive
awareness of
hunger and satiety
– Alexithymia
– Binge eating
– Eating styles
– Problems food
intake
– Use of amenities
– Food products for
older adults
– Dietary
recommendations
– Sustainable
behaviour
– Change in sleep
and 
change in appetite
118


118
184

118
184










X



118








118


118


MicMac study
(LASA ancillary study)

X
Oral health
X2126
126
Physical activityIM
046
046 046 046 046 046 046 046 046 046 046 046
Daily Physical Activity** 162
Early life physical
activity

246
Perceived physical
activity (LIVAS)
– scaled
114

314
114

314
114

314
114

314
114

314
114

314












 –

Accelerometry
(LASA ancillary studies)
– subsample (St. 1)
– subsample (St. 2)
– subsample (St. 3)
– subsample (St. 4)

































X2





X






X3


















X
 





Sedentary behavior
– scaled
– scaled













101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
SmokingIM
154154154154154154154154154154154154
/topics/Medication/
supplements
BCDE2BFGH3BMBI4J
Medication and
food supplement
use4
– types of
medication

152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
152


352
Food supplement
use4
– Vitamin D use
included





















174

374
174

374
PainBCDE2BFGH3BMBIJ
Subjective painIM

– scaled

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

115

315

 115

315

Dealing with pain**
188
 
Pain drawing
188
 
Perception:
Vision
BCDE2BFGH3BMBIJ
Vision (self-report)IM
– total scores
– tel. proxy*
– tel. respondent*

031
231



031
231

604
604
031
231

604
704
031
231

604
704
031
231



031
231

604
704
031
231

604
704
031
231

604
704
031
231



031
231



031
231

604
704
031
231

604
704
Visual acuity test

– Vision-related
quality of life







191

192



191

192
191

192
191

192
191





 –

Vision: contrast
sensitivity

157157157157157157
Perception:
Hearing
BCDE2BFGH3BMBIJ
Hearing (self-report)IM
– total scores
– tel. proxy*
– tel. respondent*

031
231



031
231

604
604
031
231

604
704
031
231

604
704
031
231



031
231

604
704
031
231

604
704
031
231

604
704
031
231



031
231



031
231

604
704
031
231
604
704
Hearing: Speech
in Noise Test (SNT)

Hearing: SNT
questions









193


194



193


194
193


194









193


194



Perception: smellBCDE2BFGH3BMBIJ
Olfactory function
S00
S01
S02
S00
S01
S02
Physical
functioning
BCDE2BFGH3BMBIJ
Functional
limitations (ADL)IM
– constructed
– tel. proxy*
– tel. respondent*


– Use of assistive
devices or
assistance

– Limitations in
joint mobility

030

230




030


030

230

603
603


030


183
030

230

603
703

030


183
030

230

603
703

030


183
030

230




030


030

230

603
703

030


030

230

603
703

030


030

230

603
703

030


030

230




030


030

230




030


030

230

603
703

030


030

230

603
703

030


Global Activity Limitations**

– tel. respondent*
033

033

603
033

703
033

703
033

033

703
033

703
033

703
033



033

703
033

703
Physical
performance

034034034034034034034034034034034 034
Pulmonary function test
– Peak Flow

– Spirometry (post
bronchodilator)

158

158

158

158





158

158



168






Grip strength
161161161161161161161161161161 161
Quality of life
BCDE2BFGH3BMBIJ
EuroQol
– scaled




135
335

135
335
135
335
135
335
135
335

135
335

Qualeffo-41
– (non)response
– Qualeffo scores
– scaled







o80
o81
o82
















SF-12 Health Survey
– scaled
– scaled (Am.)





133
333
533
133
333
533


133
333
533
133
333
533
133
333
533
133
333
533


133
333
533
133
333
533
WHO Quality of Life**
133
133
Self-rated health
– GHPQ
– GHPQ: scaled
– tel. proxy*
– tel. respondent*

036
113
313


036
113
313

602
602
036
113
313

602
702
036
113
313

602
702
036
113
313


036
113
313

602
702
036
113
313

602
702
036
113
313

602
702
036
113
313


036


036


602
702
036


602
702
LASA-wave BCDE2BFGH3BMBIJK

* Files in the 700 series contain data from telephone interviews held with respondents, while files in the 600 series contain data from telephone interviews held with proxies. In wave C however, the same questionnaire was used for both respondent and proxy; data was stored in the 600 series.

** Not yet documented

1 Fertility (Women) moved from self-administered questionnaire (LASAB119) to medical interview (LASAC181 / LAS2B181 / LAS3B181 / LASMB181)
2 As part of the Lifestyle study
3 As part of the EPOSA study
4 In wave I Food supplement questions moved to LASA174
IM In 2004, three years after wave E an interim measurement was carried out on the first cohort, see the specific topics for more details. More information will follow.